Group B streptococcal infection

Clinical trials for Group B streptococcal infection explained in plain language.

Never miss a new study

Get alerted when new Group B streptococcal infection trials appear

Sign up with your email to follow new studies for Group B streptococcal infection, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Could a vaccine shield newborns from a deadly bacterial infection?

Vaccine Completed

This study tests an experimental vaccine called GBS-NN/NN2 against Group B Streptococcus (GBS), a bacteria that can cause serious infections in newborns. The trial includes pregnant women both with and without HIV, giving two doses between 26 and 30 weeks of pregnancy. Researcher…

Matched conditions: GROUP B STREPTOCOCCAL INFECTION

Phase 2 • Sponsor: Minervax ApS • Aim: Vaccine

Last updated Jul 16, 2026 00:00 UTC

Group B streptococcal infection

Get alerted when new Group B streptococcal infection trials appear

Could a vaccine shield newborns from a deadly bacterial infection?